Trial Information

Summary: A study to evaluate treatment with SYR-619 in Subjects with Type 2 Diabetes

To evaluate the efficacy of a study drug treatment on HbA1c change from baseline in subjects with T2DM that have not previously achieved adequate glycemic control with lifestyle modification or metformin or sulfonylurea oral antidiabetic monotherapy.

Several Study Inclusion Criteria Include:

• Male or female 18 years of age or older with a historical diagnosis of type 2 diabetes mellitus
• Hemoglobin > or = to 12g/dl for males and > or = 10g/dl for females
• Treatment for diabetes with either lifestyle modification or metformin or sulfonylurea alone for at least the 2 months prior to screening

Several Study Exclusion Criteria Include:

• Concurrently treated with combined metformin and sulfonylurea antidiabetic therapy
• History of cancer, other than squamous cell or basal cell carcinoma of the skin.
• History of coronary angioplasty, coronary stent placement, coronary bypass surgery or myocardial infarction

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:46:34 AM